Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease
1 other identifier
observational
50
1 country
1
Brief Summary
Determination of IRTI (infrared thermal imaging) can be used to evaluate PAD patients with critical limb ischemia with different degrees of lesion. IRTI can be used to evaluate the foot blood perfusion after percutaneous transluminal angioplasty (PTA) treatment and determine the success rate of surgery. IRTI can be used as an effective follow-up tool for patients after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 4, 2023
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJuly 18, 2023
July 1, 2023
1 year
July 4, 2023
July 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the validity and reliability of IRTI in assessing foot blood perfusion and surgical success rate after PTA treatment.
The different levels of pseudocodes (white, red, pink, yellow, green, blue, and black) represent the corresponding IRTI, corresponding to the color bar from low to high temperature. We will measure the average temperature of the dorsum and sole of the foot before and after PTA treatment in the operated and non-operated limbs. Ankle-brachial index (ABI) of the operated and non-operated limbs before and after PTA treatment will also be measured. We will analyze the agreement between ABI and foot temperature in the operated and non-operated limbs, as well as the agreement between the change in ABI and foot temperature.
up to 15 months
Eligibility Criteria
PAD patients who came to our hospital for diagnosis and treatment were initially selected, and those who met the indications for PTA surgery were finally included in the study.
You may qualify if:
- Patients with Rutherford grade 3, 4, 5, or 6.
- Patients with indications for lower extremity arterial PTA: severe intermittent claudication, rest pain, ulceration or gangrene.
- Patients who required PTA of only one limb (left versus right).
You may not qualify if:
- Patients with body temperature above 37 ° C.
- Patients with indications for open surgery.
- Patients requiring major amputation (above the ankle).
- Patients with acute occlusive or embolic limb ischemia.
- Patients with deep venous thrombosis of the lower extremity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fangge Denglead
Study Sites (1)
Fangge Deng
Guangzhou, Guangdong, 510163, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- : Principal Investigator
Study Record Dates
First Submitted
July 4, 2023
First Posted
July 12, 2023
Study Start
March 1, 2023
Primary Completion
March 1, 2024
Study Completion
June 1, 2024
Last Updated
July 18, 2023
Record last verified: 2023-07